Research Activity – Page 31

AstraZeneca and Daiichi Sankyo’s Dato-DXd Fails to Meet Overall Survival Goal in NSCLC Study, FDA Decision Looms

8 months ago talkbio0Tagged AstraZeneca, Clinical Research, Daiichi, Dato-DXd, Datopotamab deruxtecan, Decision, Non-Small Cell Lung Carcinoma, Overall Survival, Sankyo, TROPION-Lung01, United States Food and Drug Administration

AstraZeneca, Daiichi Sankyo, Dato-DXd (datopotamab deruxtecan), Non-small cell lung cancer (NSCLC), Overall survival (OS), FDA decision, TROPION-Lung01 study

Eli Lilly Expands AI Capabilities with $409M Genetic Leap Partnership

8 months ago talkbio0Tagged AI, Artificial Intelligence, Drug Discovery, Drug Industry, Eli, Eli Lilly, Genetic Leap, RNA

Eli Lilly, AI, Genetic Leap, drug discovery, RNA specialist, pharmaceutical industry

Superluminal Medicines Secures $120M Series A Funding to Advance Membrane Receptor Drugs into Clinical Trials

8 months ago talkbio0Tagged AI-focused, Clinical Trials, Eli, Eli Lilly, Funding, Investments, Membrane receptor, Series, Superluminal Medicines

Superluminal Medicines, Series A funding, membrane receptor drugs, clinical trials, AI-focused biotech, Eli Lilly investment